Thanks to decades of accumulated expertise, the company manages both the development of its own projects and those of third-party clients, maintaining a strong presence in European and international markets.
The Bioindustria Laboratorio Italiano Medicinali facility in Novi Ligure (AL), Italy, is dedicated to manufacturing both sterile medicines (including large and small volume injectable solutions and freeze-dried products) and non-sterile products (such as tablets and capsules). The company’s operations are regularly inspected by the Italian Medicines Agency (AIFA), and since 2013 the site has also been subject to inspections by the U.S. FDA — with the most recent FDA inspection in 2018 concluding without issuance of Form 483 observations.